Corbus Pharmaceuticals Holdings, Inc. (CRBP) Wednesday announced that it has appointed Dominic Smethurst as its chief medical officer.
Smethurst has over 20 years of experience in the pharmaceutical and biotechnology sector, including the UK's National Health Service. Most recently he was the CMO of Bicycle Therapeutics.
In pre-market activity, Corbus shares are trading at $26.75, up 2.61% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.